Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell population
Daryle J. DePianto, Jason A. Vander Heiden, Katrina B. Morshead, Kai-Hui Sun, Zora Modrusan, Grace Teng, Paul J. Wolters, Joseph R. Arron
Daryle J. DePianto, Jason A. Vander Heiden, Katrina B. Morshead, Kai-Hui Sun, Zora Modrusan, Grace Teng, Paul J. Wolters, Joseph R. Arron
View: Text | PDF
Research Article Aging Pulmonology

Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell population

  • Text
  • PDF
Abstract

Compromised regenerative capacity of lung epithelial cells can lead to cellular senescence, which may precipitate fibrosis. While increased markers of senescence have been reported in idiopathic pulmonary fibrosis (IPF), the origin and identity of these senescent cells remain unclear, and tools to characterize context-specific cellular senescence in human lung are lacking. We observed that the senescent marker p16 is predominantly localized to bronchiolized epithelial structures in scarred regions of IPF and systemic sclerosis–associated interstitial lung disease (SSc-ILD) lung tissue, overlapping with the basal epithelial markers Keratin 5 and Keratin 17. Using in vitro models, we derived transcriptional signatures of senescence programming specific to different types of lung epithelial cells and interrogated these signatures in a single-cell RNA-Seq data set derived from control, IPF, and SSc-ILD lung tissue. We identified a population of basal epithelial cells defined by, and enriched for, markers of cellular senescence and identified candidate markers specific to senescent basal epithelial cells in ILD that can enable future functional studies. Notably, gene expression of these cells significantly overlaps with terminally differentiating cells in stratified epithelia, where it is driven by p53 activation as part of the senescence program.

Authors

Daryle J. DePianto, Jason A. Vander Heiden, Katrina B. Morshead, Kai-Hui Sun, Zora Modrusan, Grace Teng, Paul J. Wolters, Joseph R. Arron

×

Figure 2

Establishing in vitro senescent lung epithelial cell models.

Options: View larger image (or click on image) Download as PowerPoint
Establishing in vitro senescent lung epithelial cell models.
(A) SAECs s...
(A) SAECs stained for senescence-associated β-galactosidase activity (SAβ-Gal) at 5 days after treatment (control: DMSO/H2O2 at 50 nM, senescence-inducing: doxorubicin/H2O2 at 100 nM). (B) Immunofluorescence (IF) staining for Ki-67 and Actin in SAECs at 5 days after treatment. (C) Quantification of SAEC area from representative fields (mean ± SD, n = 10) after induction of senescence by doxorubicin (day 5). ***P < 0.005 (unpaired 2-tailed Student’s t tests). (D) CDKN2A (mean ± SD, n = 4 biological replicates) gene expression in nonsenescent (DMSO/H2O2 50 nM) and senescent (doxorubicin/H2O2 100 nM) cultures at day 5. ***P < 0.005 (unpaired 2-tailed Student’s t tests). (E) IF staining for p16 and actin in SAECs at day 5 after treatment. (F) SASP gene expression, CSF2, IL6, and CXCL8, (mean ± SD, n = 4 biological replicates) in nonsenescent (DMSO/H2O2 50 nM) and senescent (doxorubicin/H2O2 100 nM) cultures at day 5. ***P < 0.005 (unpaired 2-tailed Student’s t tests). (G) Quantification of secreted SASP proteins, GM-CSF, IL-6, IL-8, (mean ± SD, n = 3 biological replicates) in supernatants of treated SAEC cultures over a 48-hour period (day 5 to day 7 after initiation of treatment). ***P < 0.005 (unpaired 2-tailed Student’s t tests). (H) Relative cell number in SAEC cultures at day 4 cultured in SAGM basal media, conditioned media from control cultures (CM-Cont), or conditioned media from senescent SAEC cultures (CM-Sen) (mean ± SD, n = 3). **P < 0.05, ***P < 0.005 (Tukey’s multiple comparisons test). (I) SAβ-Gal stainings of SAEC cultures at day 4. (J) Quantification of percentage of senescent cells in SAEC cultures treated with conditioned media at day 4 (mean ± SD, n = 3). ***P < 0.005 (Tukey’s multiple comparisons test). Scale bars: 100 μm (A and I), 40 μm (B), 40 μm (E).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts